Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-d…

Mechanistic description

Soluble amyloid oligomers may injure cholinergic terminals via CHRNA7-linked calcium dysregulation, making cholinergic dysfunction an early downstream readout of amyloid toxicity. This remains mechanistically plausible but is not a strong lead translational thesis.

Mechanism / pathway

APP, CHRNA7
→
neurodegeneration

Evidence for (5)

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation and synaptic dysfunction.

PMID:20164328 2010 Neuropharmacology
Alpha7 nicotinic receptor agonists protect against beta-amyloid toxicity.

PMID:25959067 2015 Neurobiol Aging
Alpha7 nicotinic receptors in amyloid-beta binding and tau phosphorylation.

PMID:23627750 2014 Neuropharmacology
Targeting alpha7 nicotinic receptors for Alzheimer's disease therapy.

PMID:24269557 2014 Neuropharmacology
Alpha7 nAChR agonists attenuate amyloid-beta induced cholinergic dysfunction.

PMID:40724534 2025 Brain Res

Evidence against (2)

Aβ-CHRNA7 binding and functional relevance are inconsistent across preparations and model systems, with weak human specificity for cholinergic terminals.
Alpha7-targeted cognition programs have had a poor clinical track record, limiting confidence in translational value.

Evidence matrix

5 supporting 2 contradicting

47% posterior support

Supporting

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation and synaptic dysfunction. PMID:20164328 · 2010 · Neuropharmacology
Alpha7 nicotinic receptor agonists protect against beta-amyloid toxicity. PMID:25959067 · 2015 · Neurobiol Aging
Alpha7 nicotinic receptors in amyloid-beta binding and tau phosphorylation. PMID:23627750 · 2014 · Neuropharmacology
Targeting alpha7 nicotinic receptors for Alzheimer's disease therapy. PMID:24269557 · 2014 · Neuropharmacology
Alpha7 nAChR agonists attenuate amyloid-beta induced cholinergic dysfunction. PMID:40724534 · 2025 · Brain Res

Contradicting

Aβ-CHRNA7 binding and functional relevance are inconsistent across preparations and model systems, with weak human specificity for cholinergic terminals.
Alpha7-targeted cognition programs have had a poor clinical track record, limiting confidence in translational value.

Bayesian persona consensus

47% posterior support

1 signal · 0 for / 1 against · agreement 0%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-d…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-63ef3ee258

BibTeX

@misc{scidex_hypothesis_h63ef3ee,
  title        = {Amyloid first impairs cholinergic terminals through alpha7 nicotinic receptor-d…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-63ef3ee258},
  note         = {SciDEX artifact hypothesis:h-63ef3ee258}
}